New York State Common Retirement Fund
KLRS

New York State Common Retirement Fund’s Kalaris Therapeutics KLRS Stock Holding History

New York State Common Retirement Fund’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20
Closed -$338 – 3365
2024
Q2 		$338 Sell
20
-305
-94% -$5.38K ﹤0.01% 3359
2024
Q1 		$5.64K Hold
325
– – ﹤0.01% 3210
2023
Q4 		$5.08K Sell
325
-1,170
-78% -$46.1K ﹤0.01% 3219
2023
Q3 		$73.9K Buy
1,495
+502
+51% +$34.2K ﹤0.01% 2875
2023
Q2 		$77.6K Buy
993
+677
+214% +$64.4K ﹤0.01% 3011
2023
Q1 		$28.7K Sell
316
-618
-66% -$78.7K ﹤0.01% 3073
2022
Q4 		$110K Buy
934
+361
+63% +$61.2K ﹤0.01% 2937
2022
Q3 		$104K Buy
573
+4
+0.7% +$623 ﹤0.01% 3005
2022
Q2 		$51K Sell
569
-3
-0.5% -$315 ﹤0.01% 3216
2022
Q1 		$89K Sell
572
-352
-38% -$70.2K ﹤0.01% 3052
2021
Q4 		$275K Sell
924
-2
-0.2% -$928 ﹤0.01% 2752
2021
Q3 		$534K Sell
926
-228
-20% -$106K ﹤0.01% 2426
2021
Q2 		$524K Buy
1,154
+228
+25% +$118K ﹤0.01% 2572
2021
Q1 		$498K Buy
926
+217
+31% +$182K ﹤0.01% 2467
2020
Q4 		$627K Buy
709
+357
+101% +$275K ﹤0.01% 2240
2020
Q3 		$223K Buy
+352
New +$240K ﹤0.01% 2598

Other funds holding KLRS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

New York State Common Retirement Fund's KLRS Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Kalaris Therapeutics (KLRS) in Q3 2024, closing a stake of 20 shares — an estimated $338 sold.

New York State Common Retirement Fund first reported a position in KLRS in Q3 2020 and held it in 16 quarters. The position peaked at $627K in Q4 2020. 59 funds tracked by Wall St. Rank hold KLRS as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Kalaris Therapeutics position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 20 Kalaris Therapeutics shares in Q3 2024, an estimated $338.
  • New York State Common Retirement Fund first reported a position in Kalaris Therapeutics in Q3 2020 and held it in 16 quarters.
  • New York State Common Retirement Fund's Kalaris Therapeutics position peaked at $627K in Q4 2020.
  • 59 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.